Related Experiment Video
Updated: May 6, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Inhibition of PINK1 senses ROS signaling to facilitate neuroblastoma cell pyroptosis
Yuyuan Zhu1,2, Min Cao1,2, Yancheng Tang1,2
1The Affiliated XiangTan Central Hospital of Hunan University, School of Biomedical Sciences, Hunan University, Changsha, Hunan, China.
Abstract:
Mitochondria serve as the primary source of intracellular reactive oxygen species (ROS), which play a critical role in orchestrating cell death pathways such as pyroptosis in various types of cancers. PINK1-mediated mitophagy effectively removes damaged mitochondria and reduces detrimental ROS levels, thereby promoting cell survival. However, the regulation of pyroptosis by PINK1 and ROS in neuroblastoma remains unclear. In this study, we demonstrate that inhibition or deficiency of PINK1 sensitizes ROS signaling and promotes pyroptosis in neuroblastoma cells via the BAX-caspase-GSDME signaling pathway. Specifically, inhibition of PINK1 by AC220 or knockout of PINK1 impairs mitophagy and enhances ROS production, leading to oxidation and oligomerization of TOMM20, followed by mitochondrial recruitment and activation of BAX. Activated BAX facilitates the release of CYCS (cytochrome c, somatic) from the mitochondria into the cytosol, activating CASP3 (caspase 3). Subsequently, activated CASP3 cleaves and activates GSDME, inducing pyroptosis. Furthermore, inhibition or deficiency of PINK1 potentiates the anti-tumor effects of the clinical ROS-inducing drug ethacrynic acid (EA) to inhibit neuroblastoma progression in vivo. Therefore, our study provides a promising intervention strategy for neuroblastoma through the induction of pyroptosis.Abbreviation: AC220, quizartinib; ANOVA, analysis of variance; ANXA5, annexin A5; BAX, BCL2 associated X, apoptosis regulator; BAK1, BCL2 antagonist/killer 1; CCCP, carbonyl cyanide m-chlorophenyl hydrazone; COX4/COX IV, cytochrome c oxidase subunit 4; CS, citrate synthase; CSC, cancer stem cell; CYCS, cytochrome c, somatic; DTT, dithiothreitol; DNA, deoxyribonucleic acid; EA, ethacrynic acid; Fer-1, ferroptosis inhibitor ferrostatin-1; FLT3, fms related tyrosine kinase 3; GSDMD, gasdermin D; GSDME, gasdermin E; kDa, kilodalton; LDH, lactate dehydrogenase; MFN1, mitofusin 1; MFN2, mitofusin 2; mito, mitochondria; mito-ROS, mitochondrial ROS; mtKeima, mitochondria-targeted monomeric keima-red; ml, microliter; MT-CO2, mitochondrially encoded cytochrome c oxidase II; NAC, antioxidant N-acetyl-L-cysteine; Nec-1, necroptosis inhibitor necrostatin-1; OMA1, OMA1 zinc metallopeptidase; OMM, outer mitochondrial membrane; PARP, poly(ADP-ribose) polymerase; PBS, phosphate-buffered saline; PI, propidium iodide; PINK1, PTEN induced kinase 1; PRKN/Parkin, parkin RBR E3 ubiquitin protein ligase; Q-VD, Q-VD-OPH; ROS, reactive oxygen species; sg, single guide; sh, short hairpin; STS, staurosporine; TOMM20, translocase of outer mitochondrial membrane 20; TIMM23, translocase of inner mitochondrial membrane 23; μm, micrometer; μM, micromolar.
Insights
Inhibition of PTEN induced kinase 1 (PINK1) in neuroblastoma enhances reactive oxygen species (ROS) and triggers pyroptosis, offering a new cancer therapy strategy. This study reveals PINK1 deficiency promotes pyroptosis via the BAX-caspase-GSDME pathway.
Area of Science:
- Cell Biology
- Oncology
- Mitochondrial Biology
Background:
- Mitochondria are key sources of reactive oxygen species (ROS), influencing cancer cell death pathways like pyroptosis.
- PTEN induced kinase 1 (PINK1)-mediated mitophagy removes damaged mitochondria and reduces ROS, promoting cell survival.
- The role of PINK1 and ROS in neuroblastoma pyroptosis is not well understood.
Purpose of the Study:
- To investigate the regulation of pyroptosis by PINK1 and ROS in neuroblastoma cells.
- To elucidate the signaling pathway involved in PINK1-modulated pyroptosis.
- To evaluate the therapeutic potential of targeting PINK1 in neuroblastoma treatment.
Main Methods:
- Inhibition of PINK1 using AC220 or genetic knockout (PINK1).
- Assessment of mitophagy, ROS production, TOMM20 oxidation, and BAX activation.
- Analysis of cytochrome c release, caspase activation, and Gasdermin E (GSDME) cleavage.
- In vivo studies evaluating the combined effect of PINK1 inhibition and ethacrynic acid (EA).
Main Results:
- PINK1 inhibition or deficiency impaired mitophagy and increased ROS production in neuroblastoma cells.
- This led to TOMM20 oxidation, BAX activation, cytochrome c release, and subsequent caspase-3 and GSDME activation, inducing pyroptosis.
- Combined inhibition of PINK1 and treatment with the ROS-inducing drug ethacrynic acid (EA) showed enhanced anti-tumor effects in vivo.
Conclusions:
- PINK1 deficiency sensitizes neuroblastoma cells to ROS signaling, promoting pyroptosis through the BAX-caspase-GSDME pathway.
- Targeting PINK1 enhances the efficacy of ROS-inducing agents, presenting a novel therapeutic strategy for neuroblastoma.
- This study provides a promising intervention strategy for neuroblastoma by inducing pyroptosis.
More Related Videos
12:35Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
Published on: April 14, 2023
09:20Author Spotlight: Exploring Mitochondrial Function and Chemical Toxicity Using Drosophila melanogaster
Published on: November 10, 2023
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway